This Government Contract opportunity from Department Of Health And Human Services was posted on August 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Transcriptomic characterization of plasma exosomes
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This acquisition by the National Institutes of Health aims to procure essential consumables and reagents required for the transcriptomic characterization of 650 plasma exosomal RNA samples. The project, conducted by the Center for Research on Genomics and Global, focuses on investigating the gene expression profiles of plasma exosomes to better understand the pathophysiology of cardiometabolic diseases and identify potential novel biomarkers. The research utilizes molecular biology techniques to analyze plasma, a minimally invasive biological fluid, to elucidate disease mechanisms across diverse populations. The necessary products for next-generation sequencing will be generated using the Illumina platform currently available through the core laboratory supporting this initiative. The contract specifies that the required consumables and reagents will be supplied by New England Biolabs. This special notice was posted on August 20, 2026, with a response deadline of August 31, 2026. The performance of this contract is located in Bethesda, Maryland, under the Department of Health and Human Services.
General Info
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The primary purpose of this acquisition is to obtain consumables and reagents essential for processing 650 plasma exosomal RNA samples for next generation sequencing. The Center for Research on Genomics and Global employs various molecular biology techniques to investigate the pathophysiology of cardiometabolic diseases and associated traits across diverse populations. This project aims to characterize the gene expression profile of plasma exosomes, which are implicated in several diseases. Plasma, a biological fluid collected via minimally invasive methods, serves as an indicator of health and disease status. Molecular analysis of plasma may further elucidate disease mechanisms and facilitate the discovery of novel biomarkers. Consumables and reagents supplied by New England Biolabs (NEB) are utilized in generating all necessary products for sequencing on the Illumina platform, the system currently available to NHGRI investigators through the core laboratory supporting this ongoing project.
More opportunities from Department Of Health And Human Services → National Institutes Of Health
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
